All insights
Markets

Norrsken VC leads $20M Series A in Vocca's AI phone assistant for medical practices

Vocca says 15,000 practitioners now use its call-handling system, up from 2,000 a year ago, and plans a deeper push into the United States.

By World Nexus Group Editorial

1 source

Vocca, a Paris and New York company that sells an AI phone assistant to medical practices, said on 8 October 2026 that it had raised a $20M Series A led by Norrsken VC 1. Heal Capital, Speedinvest and Firstminute Capital joined the round, which takes Vocca's total funding to $25 million 1.

What the company reports

Vocca's first product answers and handles patient calls on behalf of practices 1. The company says 15,000 medical practitioners now use it, against 2,000 a year earlier, spread across 1,500 practices and twenty specialties in the US and Europe 1. Over the same year, it says, monthly conversation volume rose 10x to more than one million, and revenue grew 7x 1. It does not disclose revenue in absolute terms or a valuation.

On performance, Vocca says it resolves 70% of conversations from start to finish without a person stepping in, rising above 85% for its most established customers 1. It names two reference accounts: DAG Dental, a group of 37 practices that runs its scheduling on the system, and the Hôpital Fondation de Rothschild, which uses it for intake, calls and confirmations across 350,000 patients a year 1.

The company was founded in July 2024 by Eliott Hoffenberg and Hugo Danet, employs around 40 people and plans to hire 40 more by the end of the year 1. It says the money will go on channels beyond voice, more specialties and a larger presence in the United States 1.

What it means for the market

The round is a European-led bet on administrative AI in outpatient care. Norrsken VC, based in Stockholm, describes itself as an early-stage impact fund with more than €500M under management and 60+ investments 1. With a lead investor from Stockholm and staff split between Paris and New York, the stated plan is to use the money to grow further in the US 1.

Vocca frames the opportunity as a second stage of healthcare AI after documentation tools. Its argument is that ambient scribes became standard within a few years, and that call handling can spread faster because patients keep phoning and staff keep their existing software 1. It cites two pressures behind demand: four in ten calls to a medical practice go unanswered, and nearly half of health workers report frequent burnout 1. It also says a quarter of US health spending still goes on administration 1.

For buyers, the selling points Vocca stresses are integration with the systems practices already run, specialty-specific scheduling models and go-live in days rather than months 1. For investors, the growth figures put it in a crowded field of voice agents competing for the same front-desk budget, where adoption claims will need independent checking.

Caveats

All of the usage, resolution and growth figures come from Vocca's own announcement and have not been independently verified 1. The resolution rate is an average across customers rather than a measured outcome for patients or staff, and the announcement gives no data on errors, missed escalations or patient satisfaction 1. Vocca's stated next step is a deeper push into the United States alongside new channels and specialties 1.

References

  1. 1Vocca raises $20M after growing from 2,000 to 15,000 medical practitioners in a year · PR Newswire

This briefing summarises publicly available research and reporting for information only. It is not medical, investment or legal advice. Follow the references to the primary sources.